By activating GLP-1 receptors, Wegovy: Delays gastric emptying : Food remains in the stomach longer, promoting satiety but potentially causing nausea, bloating, and early fullness
Protagonist Therapeutics
It may be a good option for those who do not need support with constipation
This ensures the needle reaches the subcutaneous layer where the medication absorbs optimally
Such off-label use, i.e., made in the absence of an FDA approval for this indication, in itself is reason for carefully conducted, evidence-based clinical trials, say the researchers, who reported results in JAMA Psychiatry
GLP-1 stands for glucagon-like peptide-1 , a hormone your body naturally releases after you eat